Stenting and extracorporeal shock wave lithotripsy in chronic XXXX .

@entity1 @entity788 @entity1157 @entity158
BACKGROUND: Early observational studies of endoscopic treatment and extracorporeal shock wave lithotripsy (ESWL) reported considerable or complete relief of @entity158 in 50%-80% of @entity1 with chronic @entity788 . There is no consensus on the measurement of @entity158 , making comparison of observational studies difficult, and little attention has been paid to the type and amount of analgesics used by @entity1 before and after decompressive treatment. METHODS: We performed a retrospective study of all @entity1 with chronic @entity788 and @entity1157 and receiving decompressing treatment between 1 November 1994 and 31 July 1999. Primary parameters were type and amount of analgesics used. RESULTS: Forty-nine @entity1 with chronic @entity788 and @entity1157 received stenting of the pancreatic duct (28 @entity1 ), ESWL (6 @entity1 ) or both (15 @entity1 ). After a median follow-up of 21 months, 35% of all @entity1 were @entity158 -free and a further 6% were not using analgesics. Seven @entity1 no longer needed opioids during follow-up, but five other @entity1 needed addition of opioids to treatment. The median opioid dose among opioid-dependent @entity1 rose slightly (9%). The median increase of weight after treatment was 1 kg per year. CONCLUSION: After decompressive treatment of @entity1 with chronic @entity788 and @entity1157 , we observed a small increase in weight and a small reduction in the number of opioid users. The changes may not be different from the natural course of the disease.
